Role of AMP-activated protein kinase in healthy and diseased hearts

被引:114
作者
Dolinsky, Vernon W.
Dyck, Jason R. B. [1 ]
机构
[1] Univ Alberta, Heritage Med Res Ctr 474, Cardiovasc Res Grp, Dept Pediat,Fac Med & Dent, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Pharmacol, Cardiovasc Res Grp, Fac Med & Dent, Edmonton, AB T6G 2S2, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2006年 / 291卷 / 06期
关键词
ischemia; cardiac hypertrophy; cardiac energy metabolism; glycogen;
D O I
10.1152/ajpheart.00329.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The heart is capable of utilizing a variety of substrates to produce the necessary ATP for cardiac function. AMP-activated protein kinase (AMPK) has emerged as a key regulator of cellular energy homeostasis and coordinates multiple catabolic and anabolic pathways in the heart. During times of acute metabolic stresses, cardiac AMPK activation seems to be primarily involved in increasing energy-generating pathways to maintain or restore intracellular ATP levels. In acute situations such as mild ischemia or short durations of severe ischemia, activation of cardiac AMPK appears to be necessary for cardiac myocyte function and survival by stimulating ATP generation via increased glycolysis and accelerated fatty acid oxidation. Whereas AMPK activation may be essential for adaptation of cardiac energy metabolism to acute and/or minor metabolic stresses, it is unknown whether AMPK activation becomes maladaptive in certain chronic disease states and/or extreme energetic stresses. However, alterations in cardiac AMPK activity are associated with a number of cardiovascular-related diseases such as pathological cardiac hypertrophy, myocardial ischemia, glycogen storage cardiomyopathy, and Wolff-Parkinson-White syndrome, suggesting the possibility of a maladaptive role. Although the precise role AMPK plays in the diseased heart is still in question, it is clear that AMPK is a major regulator of cardiac energy metabolism. The consequences of alterations in AMPK activity and subsequent cardiac energy metabolism in the healthy and the diseased heart will be discussed.
引用
收藏
页码:H2557 / H2569
页数:13
相关论文
共 146 条
[1]   Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site [J].
Adams, J ;
Chen, ZP ;
Van Denderen, BJW ;
Morton, CJ ;
Parker, MW ;
Witters, LA ;
Stapleton, D ;
Kemp, BE .
PROTEIN SCIENCE, 2004, 13 (01) :155-165
[2]   Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin [J].
Allard, MF ;
Wambolt, RB ;
Longnus, SL ;
Grist, M ;
Lydell, CP ;
Parsons, HL ;
Rodrigues, B ;
Hall, JL ;
Stanley, WC ;
Bondy, GP .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (03) :E487-E493
[3]   CONTRIBUTION OF OXIDATIVE-METABOLISM AND GLYCOLYSIS TO ATP PRODUCTION IN HYPERTROPHIED HEARTS [J].
ALLARD, MF ;
SCHONEKESS, BO ;
HENNING, SL ;
ENGLISH, DR ;
LOPASCHUK, GD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :H742-H750
[4]   Myocardial ischemia differentially regulates LKB1 and an alternate 5′-AMP-activated protein kinase kinase [J].
Altarejos, JY ;
Taniguchi, M ;
Clanachan, AS ;
Lopaschuk, GD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) :183-190
[5]   β-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload [J].
An, D ;
Kewalramani, G ;
Qi, D ;
Pulinilkunnil, T ;
Ghosh, S ;
Abrahani, A ;
Wambolt, R ;
Allard, M ;
Innis, SM ;
Rodrigues, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (06) :E1120-E1127
[6]   Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy [J].
Arad, M ;
Moskowitz, IP ;
Patel, VV ;
Ahmad, F ;
Perez-Atayde, AR ;
Sawyer, DB ;
Walter, M ;
Li, GH ;
Burgon, PG ;
Maguire, CT ;
Stapleton, D ;
Schmitt, JP ;
Guo, XX ;
Pizard, A ;
Kupershmidt, S ;
Roden, DM ;
Berul, CI ;
Seidman, CE ;
Seidman, JG .
CIRCULATION, 2003, 107 (22) :2850-2856
[7]   Selective activation of AMPK-PGC-1α or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation [J].
Atherton, PJ ;
Babraj, JA ;
Smith, K ;
Singh, J ;
Rennie, MJ ;
Wackerhage, H .
FASEB JOURNAL, 2005, 19 (02) :786-+
[8]  
Atkinson D E, 1970, Adv Enzyme Regul, V9, P207
[9]   MALONYL-COA METABOLISM IN CARDIAC MYOCYTES AND ITS RELEVANCE TO THE CONTROL OF FATTY-ACID OXIDATION [J].
AWAN, MM ;
SAGGERSON, ED .
BIOCHEMICAL JOURNAL, 1993, 295 :61-66
[10]   Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD [J].
Baas, AF ;
Boudeau, J ;
Sapkota, GP ;
Smit, L ;
Medema, R ;
Morrice, NA ;
Alessi, DR ;
Clevers, HC .
EMBO JOURNAL, 2003, 22 (12) :3062-3072